Robert E. Geertsma, M.Sc., Senior Scientist, Centre for Health Protection RIVM ‐ National Institute for Public Health and the Environment, Bilthoven (NL) talks at the Clinam Summit in 2017 about safety considerations on the route to the market.
About the Clinam Foundation:
The European Foundation for Clinical Nanomedicine is a non-profit institution aiming at advancing medicine to the benefit of individuals and society through the application of nanoscience. Aiming at prevention, diagnosis, and therapy through nanomedicine as well as at exploration of its implications, the Foundation reaches its goals through support of clinically focussed research and of interaction and information flow between clinicians, researchers, the public, and all stakeholders. The recognition of the large future impact of nanoscience on medicine and the observed rapid advance of medical applications of nanoscience have been the main reasons for the creation of the Foundation.